Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Gastroenterology
•
Advanced Endoscopy
What factors influence your choice of EMR vs ESD vs FTR for gastric neoplastic lesions?
Related Questions
Which patients would benefit from pancreatic duct stents in combination with rectal indomethacin for prophylaxis against post-ERCP pancreatitis?
Do you routinely use single-use duodenoscopes for ERCPs in patients with a history of infections secondary to MDR organisms?
Do you feel there is any difference between performing an ERCP with an EDGE together in a single session or separately in two sessions in a patient with Roux-en-Y anatomy?
What do you consider an optimal interval of time to repeat necrosectomies for treatment of WON?
When do you send for genetic testing (e.g., SPINK1, PRSS1, CFTR) in a patient with recurrent or chronic pancreatitis without an obvious etiology and how does it impact your management?
Under what circumstances would you recommend early fecal microbiota transplantation over antibiotic treatment or bezlotoxumab in a patient with recurrent C. difficile infection?
What diet do you recommend for patients with inflammatory bowel disease?
How do you counsel patients on the use of compounded weight loss medications?
Is there a role for use of dupilumab for hypereosinophilic GI disorders distal to the esophagus?
How would you treat blue rubber bleb nevus syndrome?
